Clinical Trial News and Research

RSS

New drug to combat Gastrointestinal graft-vs.-host disease in stem-cell patients shows significant reduction in deaths

Gastrointestinal graft-vs.-host disease is a common and potentially deadly side effect for patients who undergo an allogeneic stem-cell transplant to treat certain blood cancers.

23 Jan 2007

Cetuximab may prolong survival for head and neck cancer patients

Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.

18 Jan 2007

CogState issued US patent

CogState has announced that it has been issued a patent from the Unites States Patent & Trade Mark Office (US patent no. 7,163,513) for the key technology platform used in its computer-based tests of brain function.

16 Jan 2007

New hope for Krabbe disease sufferers

By all expectations, it shouldn't have worked as well as it did. A combination of bone marrow transplantation and gene therapy greatly lengthened the lives of laboratory mice doomed by a rapidly progressing, fatal neurodegenerative disorder also found in people.

9 Jan 2007

CleveMed receives $2.3 million in funding for inpatient diagnosis of sleep disorders in cardiovascular surgery patients

Cleveland Medical Devices has announced that it has been awarded $2.3 M in NIH SBIR Phase II Continuation funding from the National Institute of Neurological Disorders and Stroke (NINDS).

7 Jan 2007

An effective malaria vaccine by 2025

A report by the world's leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine.

4 Dec 2006

Prana Biotechnology raises U.S.$6 Million to fund trial of PBT2 in patients with Alzheimer's disease.

Prana Biotechnology today announced it has entered into agreements to raise approximately A$7.77 million (US$6 million) from new institutional investors in Australia, existing institutional investors in the United States and a founding member of the Company.

20 Nov 2006

Army docs use of dangerous drug labelled irresponsible and inappropriate

American soldiers critically wounded in Iraq are being treated with a potent, experimental, blood-coagulating drug despite evidence it can cause clots in the lungs, heart and brain, leading to strokes, heart attacks and death.

20 Nov 2006

Structured exercise may enhance seniors' physical functioning

A structured exercise program may boost the physical well-being of sedentary seniors who are at risk of losing independent functioning, a new study to be published in the November 2006 Journal of Gerontology: Medical Sciences has found.

19 Nov 2006

New agreement questions NHS relation with industry

The Department of Health's new clinical trials agreement raises questions about the NHS's relation with the drug industry, says an editorial published on the British Medical Journal website.

19 Nov 2006

New technology offers alternative to open heart surgery

A new method of treating mitral regurgitation (MR), the leaking of blood through the mitral valve into the heart chamber, provides a less-invasive alternative to open heart surgery.

19 Nov 2006

Botox could fix your knees as well as your wrinkles

The preliminary results of a new study have found that Botox, better known for getting rid of wrinkles, significantly reduced severe pain from osteoarthritis of the knee and also improved the knee's function.

15 Nov 2006

Food can have an impact in preventing cancer

With cancer, researchers don't believe "you are what you eat"; that disease is always a direct result of what is, or what isn't, on your dinner plate.

14 Nov 2006

New gold standard of care for overactive bladder

A major clinical trial finds that a combination of two common medications -- tolterodine (Detrol LA) and tamsulosin (Flomax) -- works better than either drug alone for men struggling with lower urinary tract symptoms, including tough-to-treat overactive bladder (OAB).

14 Nov 2006

SpectraScience files new patent application

SpectraScience has announced that it has filed for a new patent with the United States Patent and Trademark Office.

13 Nov 2006

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

The results of a Phase I clinical trial of an experimental gene therapy aimed at treating HIV indicate that the therapy is safe and effective and also might sustain viral loads, according to a study published on Monday in the online edition of the Proceedings of the National Academy of Sciences, the AP/Washington Post reports.

8 Nov 2006

Brits to trial stem cell treatment for heart attack victims

In an experimental treatment which aims to prevent heart failure and death following a heart attack, doctors in Britain will trial a treatment which uses a patients own stem cells.

8 Nov 2006

The efficacy of Silybum marianum (L.) Gaertn. (Silymarin) in the treatment of type II diabetes

Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels.

30 Oct 2006

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

The Food and Drug Administration (FDA) has approved Tyzeka (telbivudine) for the treatment of adults with chronic hepatitis B (HBV), a serious viral infection that attacks the liver and can cause lifelong infection, scarring of the liver (cirrhosis), and eventually liver cancer, liver failure, and death.

26 Oct 2006

Race is associated with unfavorable breast cancer tumor biology

African-American women with breast cancer were more likely to have larger, later-stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment in two independent series of clinical trials examined by researchers from The University of Texas M. D. Anderson Cancer Center.

23 Oct 2006